Equities research analysts expect Israel Chemicals Ltd (NYSE:ICL) to announce earnings of $0.11 per share for the current quarter, according to Zacks. Zero analysts have made estimates for Israel Chemicals’ earnings. The lowest EPS estimate is $0.10 and the highest is $0.11. Israel Chemicals posted earnings per share of $0.09 during the same quarter last year, which would suggest a positive year-over-year growth rate of 22.2%. The company is scheduled to announce its next earnings report on Wednesday, November 14th.

On average, analysts expect that Israel Chemicals will report full-year earnings of $0.36 per share for the current financial year, with EPS estimates ranging from $0.33 to $0.39. For the next financial year, analysts anticipate that the firm will report earnings of $0.39 per share, with EPS estimates ranging from $0.36 to $0.42. Zacks Investment Research’s EPS calculations are an average based on a survey of research firms that that provide coverage for Israel Chemicals.

Israel Chemicals (NYSE:ICL) last posted its earnings results on Wednesday, August 1st. The basic materials company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.08 by $0.01. Israel Chemicals had a return on equity of 14.16% and a net margin of 22.74%. The company had revenue of $1.37 billion for the quarter. During the same period in the previous year, the company posted $0.05 EPS. Israel Chemicals’s revenue for the quarter was up 3.7% compared to the same quarter last year.

Several equities analysts have recently commented on ICL shares. ValuEngine raised Israel Chemicals from a “hold” rating to a “buy” rating in a research report on Friday, August 24th. Zacks Investment Research raised Israel Chemicals from a “hold” rating to a “buy” rating and set a $5.25 target price on the stock in a research report on Wednesday, July 11th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Israel Chemicals has an average rating of “Buy” and an average target price of $5.25.

Israel Chemicals stock opened at $5.75 on Wednesday. Israel Chemicals has a 12 month low of $3.85 and a 12 month high of $5.90. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.76 and a current ratio of 1.35. The company has a market capitalization of $7.48 billion, a PE ratio of 15.51 and a beta of 1.15.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 4th. Stockholders of record on Tuesday, August 21st were given a $0.043 dividend. This is an increase from Israel Chemicals’s previous quarterly dividend of $0.04. The ex-dividend date was Monday, August 20th. This represents a $0.17 annualized dividend and a dividend yield of 2.99%. Israel Chemicals’s dividend payout ratio is presently 32.26%.

Several institutional investors have recently bought and sold shares of ICL. Stifel Financial Corp grew its position in shares of Israel Chemicals by 276.8% in the first quarter. Stifel Financial Corp now owns 45,338 shares of the basic materials company’s stock valued at $185,000 after purchasing an additional 33,305 shares during the last quarter. Eqis Capital Management Inc. bought a new stake in shares of Israel Chemicals in the second quarter valued at approximately $245,000. A.R.T. Advisors LLC boosted its stake in shares of Israel Chemicals by 147.4% in the first quarter. A.R.T. Advisors LLC now owns 59,138 shares of the basic materials company’s stock valued at $250,000 after buying an additional 35,230 shares during the period. BlackRock Inc. boosted its stake in shares of Israel Chemicals by 13.9% in the first quarter. BlackRock Inc. now owns 113,993 shares of the basic materials company’s stock valued at $483,000 after buying an additional 13,942 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Israel Chemicals by 29.9% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 144,534 shares of the basic materials company’s stock valued at $659,000 after buying an additional 33,274 shares during the period. 8.11% of the stock is currently owned by institutional investors.

About Israel Chemicals

Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.

Further Reading: What are the Benefits of Index Funds?

Get a free copy of the Zacks research report on Israel Chemicals (ICL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.